Geulah Livshits

Geulah Livshits is a Senior Research Analyst at Chardan, with a focus on biotech equity research since March 2018. Prior experience includes a role as a Postdoctoral Fellow at Memorial Sloan Kettering Cancer Center, where research centered on epigenetic regulators in pancreatic cancer utilizing advanced techniques such as CRISPR and RNAi. Geulah Livshits has also held positions as an intern at Chardan Capital Markets, LLC, and as a consultant for The Solution Lab, Inc., performing market analyses in the biotechnology sector. Academic credentials include a PhD in Molecular Cell Biology and Development from The Rockefeller University and a Summa Cum Laude BS in Biology from Brandeis University, supplemented by a certificate in the Fundamentals of the Bioscience Industry from Stony Brook University.